Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Aromatase inhibitors cause male pattern hair loss in women.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

A woman with a scalp infection and herpes recovered fully after treatment.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Tamoxifen caused hair loss in a 52-year-old woman.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Spironolactone does not increase the risk of breast cancer recurrence.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.